Cordis Corporation: Coronary Artery Disease trials

The registry lists 42 Coronary Artery Disease studies with Cordis Corporation as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 6Phase 2 12Phase 3 15Phase 4 12No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CYPRESS - CYPHER for Evaluating Sustained SafetyStatus unknownNCT00954707Phase 4Results posted
• Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent SystemsStatus unknownNCT00715884Not applicableResults posted
• Safety and Effectiveness Study of the Ensure Medical Vascular Closure DeviceCompletedNCT00345631Phase 3Results posted
• Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232739Phase 3Results posted
• NEXUS Study for the Treatment of de Novo Native Coronary Artery LesionsCompletedNCT00231283Phase 3Results posted
• PMCF Study for Cardiology Access ProceduresCompletedNCT05543096
• An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)TerminatedNCT01202058Phase 3
• Cynergy: the CYPHER-NEVO RegistryTerminatedNCT01106378
• The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)CompletedNCT00974181Phase 3
• French Post-Marketing Surveillance SurveyTerminatedNCT00855478Phase 4
• The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.CompletedNCT00749424Phase 4
• A Study of the Presillion Stent in de Novo Coronary LesionsCompletedNCT00722579Phase 3
• Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery LesionsTerminatedNCT00606333Not applicable
• ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EUCompletedNCT00574691Phase 1
• Plug Arterial Closure System (PACS, 7F)CompletedNCT00533156Phase 2
• Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialCompletedNCT00497172Phase 4
• A Study of Diabetic Patients With De Novo Native Coronary Artery LesionsCompletedNCT00495898Phase 4
• A Multi-center Post-Market Surveillance RegistryCompletedNCT00438919Phase 4
• The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.CompletedNCT00381420Phase 3
• The Intra-Drug Eluting Stent (DES) Restenosis StudyCompletedNCT00323895Phase 4
• The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.CompletedNCT00264043Phase 2/3
• Distal Protection Combined With PTCA in AMI PatientsCompletedNCT00264030Phase 2
• CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)CompletedNCT00245401Phase 4
• The Arterial Revascularization Therapies Study Part II.CompletedNCT00235170Phase 3
• The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.CompletedNCT00235144Phase 3
• The REALITY Study - Head-to-Head Comparison Between Cypher and TaxusCompletedNCT00235092Phase 4
• The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.CompletedNCT00235066Phase 4
• A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.CompletedNCT00234455Phase 2
• FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity StentCompletedNCT00233818Phase 1/2
• The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.CompletedNCT00233805Phase 2
• FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY StentCompletedNCT00233792Phase 1/2
• Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)CompletedNCT00233779Phase 2
• Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)CompletedNCT00233766Phase 1/2
• Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery LesionsCompletedNCT00233714Phase 1/2
• A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.CompletedNCT00232856Phase 4
• The Study to Assess AMI Treated With Balloon Angioplasty.CompletedNCT00232830Phase 3
• The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher StentCompletedNCT00232804Phase 4
• The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.CompletedNCT00232791Phase 2/3
• A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)CompletedNCT00232778Phase 1/2
• Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)CompletedNCT00232765Phase 3
• Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232752Phase 3
• Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)CompletedNCT00231244Phase 3